Peptide Sciences Shut Down: What Researchers Need to Know (March 2026)

Peptide Sciences Has Closed Its Doors

On March 6, 2026, Peptide Sciences quietly ceased operations after more than a decade as one of the largest research peptide suppliers in the United States. At the time of closure, industry estimates placed the company at roughly 7.4 million dollars per month in revenue. There is no announced successor brand, no acquirer, and no pending relaunch. For the research community, that creates an immediate sourcing gap.

This page summarizes what is publicly known about the closure, what it means for outstanding orders, and how research customers are evaluating replacement vendors. Pure Chain Aminos is one such option, and we explain below why our COA-backed catalog and US-based shipping make us a worth-evaluating choice for researchers reorganizing their supply lines.

Timeline of the Shutdown

• Late February 2026 — Customers begin reporting unanswered support emails and stalled order confirmations.
• March 6, 2026 — Peptide Sciences' storefront stops processing new orders. The website remains reachable for several days but transactions fail.
• Mid-March 2026 — Industry trackers including The Peptide Catalog and LumaLex Law publish closure analyses, confirming the shutdown is voluntary rather than driven by a specific FDA enforcement action.
• April 2026 onward — The brand remains dark. No reorganization, no successor entity, no transferred catalog has been announced.

What We Know About Why

Public reporting indicates the closure was a voluntary business decision rather than the result of a named regulatory action against Peptide Sciences specifically. The broader context matters: 2025 and early 2026 brought heightened federal attention to the peptide research supply space, particularly around GLP-1 analog distribution, and several large vendors restructured or narrowed their catalogs in response. Operating costs, payment processing risk, and changing platform terms all rose sharply in this window. For a vendor at that scale, the math of staying open became harder to justify.

Importantly, no public filing names Peptide Sciences in an enforcement matter. Researchers should not infer that products previously sourced from them were defective or recalled — the closure was an operational decision, not a quality finding.

What Happens to Existing Orders

Customers with open orders at the time of closure have reported mixed outcomes. Some pre-March shipments did arrive. Many orders placed in the final days were neither fulfilled nor refunded through the storefront. Customers with credit card payments have generally had more success initiating chargebacks than those who paid via cryptocurrency. If you are still waiting on a Peptide Sciences shipment, your remaining options are typically (1) a payment processor dispute and (2) waiting for any potential customer-facing notice from a future receiver, although none has materialized.

What Current Research Customer Options Look Like

The vendor landscape has narrowed but not collapsed. Researchers evaluating replacement suppliers are weighing a recurring set of criteria:

• Certificates of Analysis — HPLC purity and mass spec identity confirmation, ideally per batch.
• Domestic shipping — US origin shipments avoid customs delays and gray-area import questions.
• Catalog breadth — vendors with single-digit SKU counts struggle to support multi-target research programs.
• Payment options — processor stability matters more than ever after the Peptide Sciences closure.
• Transparent ordering — clear pricing, clear shipping windows, and responsive support.

Why Pure Chain Aminos Is Worth Evaluating

Pure Chain Aminos is a US-based research peptide supplier with a 43-SKU catalog spanning the most-requested research targets. We provide HPLC and mass spectrometry COA data on our products, ship from within the United States, and operate with stable payment processing.

Researchers transitioning from Peptide Sciences typically begin by mapping their existing program to our top SKUs:

• BPC-157 15mg and BPC-157 10mg
• TB-500 10mg and the BPC-157 / TB-500 blend
• GLP3-R 20mg and GLP3-R 10mg
• MOTS-c 40mg
• Tesamorelin 10mg and Tesamorelin / Ipamorelin combo

For background on individual research targets, see our compound pages on BPC-157, TB-500, GLP-3 receptor research, and MOTS-c.

New Customer Coupon: WELCOME20

Researchers placing a first order with Pure Chain Aminos can apply coupon code WELCOME20 at checkout for 20% off any order of $75 or more. One use per customer.

Browse the full catalog and apply WELCOME20 at checkout »

Timeline of the Industry Reaction

The closure was sudden enough that it created a documented week-by-week ripple across the research-peptide market. Reconstructing the public timeline helps researchers understand why supply, pricing, and substitution patterns shifted the way they did.

• Week 1 (early March 2026): Researchers placing reorders began encountering checkout errors and unanswered support tickets. Reddit threads in r/Peptides and several private Discord servers logged the first reports within 48 hours.
• Week 2: Existing customers who had recently ordered reported that tracking numbers stopped updating. The Peptide Sciences customer-portal login page was replaced with a generic landing notice.
• Week 3: The Peptide Catalog and several independent peptide-review sites published the first confirmation articles, and the Lumalex Law analysis of the closure circulated widely among industry observers.
• Week 4 onward: Vendor substitution patterns stabilized. Researchers consolidated around a smaller set of established U.S.-based vendors with verifiable lab testing, and prices on common research targets such as BPC-157 and TB-500 moved roughly five to twelve percent higher across the surviving market.

For continuing coverage, see The Peptide Catalog’s article and the Lumalex Law analysis, which together remain the two most cited public references on the closure.

What Researchers Should Look For in a Replacement Vendor

The Peptide Sciences closure made one thing clear: a vendor that has been reliable for years can still leave the market with little notice. The right response is not loyalty to any single supplier but a small, repeatable evaluation framework that protects ongoing research timelines. Eight criteria stand out.

1. Independent third-party COAs. Each lot should ship with a Certificate of Analysis from a lab the vendor does not own. Look for HPLC purity, mass spec confirmation, and an endotoxin or sterility result for sterile-filtered material.
2. U.S. domestic synthesis or U.S. fulfillment. Domestic operations reduce the customs and import variables that can disrupt research schedules. Lot-to-lot consistency tends to be tighter when the same facility produces every batch.
3. Lot traceability. Each vial should carry a lot number that maps directly to a published or on-request COA. If a vendor cannot tie the vial in your hand to a specific test result, the testing claim is not auditable.
4. Cold-chain shipping. Sensitive sequences, especially GLP-class and growth-hormone-releasing peptides, benefit from insulated packaging and ice packs. Ask whether cold packs are standard or upgrade-only.
5. Transparent restocking and reshipment policy. The right time to learn a vendor’s policy on damaged or missing vials is before placing a large reorder, not after.
6. Catalog depth across the categories you actually use. A vendor strong in healing peptides but thin in GLP-class material forces split orders, which adds shipping cost and complicates lot tracking.
7. Stable payment processing. Frequent processor changes are an early indicator of business instability. A vendor that has held the same checkout flow for twelve or more months is generally on firmer footing.
8. Responsive support with a real reply window. A 24-to-72-hour response window on weekdays is a reasonable bar. Silence past that point is the same warning sign that preceded several previous vendor exits.

Pure Chain Aminos publishes COAs by lot for every product, ships from a U.S. fulfillment center, and uses cold-chain packaging on temperature-sensitive sequences. Researchers can evaluate the catalog directly: BPC-157 10mg, BPC-157 15mg, TB-500 10mg, GLP3-R 10mg, GLP2-T 30mg, NAD+ 1000mg, and Ipamorelin 5mg. Background research notes are available on the BPC-157, TB-500, and NAD+ compound pages, and the bacteriostatic water reconstitution guide covers the standard solvent workflow.

Frequently Asked Questions

1. Did Peptide Sciences shut down because of an FDA enforcement action against them specifically?
No. The publicly available reporting describes a voluntary closure. The broader regulatory environment around research peptides tightened across 2024 to 2026, but no public enforcement action against Peptide Sciences specifically has been documented.

2. Will my open Peptide Sciences orders ship?
The Peptide Catalog’s reporting indicates that fulfillment stopped abruptly. Researchers waiting on outstanding orders should check their card statement for refund posting and contact their card issuer if no credit appears within the standard chargeback window.

3. Are my saved COAs from Peptide Sciences still useful?
Saved COAs document the lots already received and remain useful for past records. They do not transfer to any other vendor, and any new vials should ship with their own current COAs from the new supplier.

4. How does Pure Chain Aminos compare on price for common research targets?
Pricing on widely studied compounds such as BPC-157 10mg and TB-500 10mg sits in the same general band as the broader U.S. research market. New researchers can use coupon code WELCOME20 for 20% off the first order of $75 or more.

5. Where can I read the related coverage on this site?
See the companion pages What happened to Peptide Sciences, Peptide Sciences coupon alternative, and Peptide Sciences alternative.

Research peptides for laboratory use only. Not approved by the FDA. Not for human consumption. By purchasing, you confirm you are a qualified researcher operating in a controlled laboratory setting.